Data2Discovery transforms organizations by applying Machine Learning and Artificial Intelligence (AI) methodologies to the client's most important business challenges. The firm is pioneering a transformative new big data approach to understand and treat disease by connecting together data in ways never tried before creating new keys to effective disease treatment. By linking diverse datasets from molecule to genome to patient, and applying machine learning patent-pending algorithms, we uncover hidden connections and new insights. Bringing together experts in drug discovery, medical research, AI/machine learning, data science, and healthcare IT, Data2Discovery uses an advanced stack of scalable graph technologies, public and proprietary data sources, patent-pending AI and machine learning, graph mining capabilities, and our extensive experience in linking and mapping data to address customers biggest problems. Knowledge creation and association mining via AI and graphs enables the capability to associate related connections and entities with a comprehensive knowledge base. AI using graphs are remarkable not just because of the possibilities they engender, but also because of their practicality. The confluence of knowledge via machine learning, graph databases, and big data provide the ability to see links between objects, and quantifies the likelihood of their occurrence. This is impossible to achieve efficiently with legacy relational database technologies.
